Company Profile LogoTESARO

TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer.

Edit IconSuggest an Edit
Health Care
Biopharma
Biotechnology
Oncology

    Unlock insights on TESARO and 60M+ companies now!

    TESARO Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

    Founded in 2010, TESARO is a privately held oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. The Company intends to leverage the experience and competencies of its management team to identify, acquire and develop promising drug candidates; and to commercialize safer and more effective products for the treatment and support of cancer patients. TESARO is developing rolapitant, a potent, selective neurokinin-1 receptor antagonist that has completed P

    Company Highlights
    Year Founded

    2010

    icon-altStatus

    Acquired

    icon-altEmployees

    65

    Location (HQ)

    USA

    Since Last Funding

    8 years 4 months

    icon-altTotal Investment Amt

    $1.1B

    Last Funding Round

    Post Ipo Equity

    icon-altMoM Headcount Growth

    -1.51%

    icon-altYoY Headcount Growth

    -13.32%

    Key Metrics

    Senior Hires

    NameLinkedin ProfilePositionDate Joined
    John Doehttps://www.linkedin.com/in/johndoeCEOCEO
    Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
    John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
    Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
    Get API access to complete private company database with growth metrics from 15 sources

    Similar Companies

    Health Care

    Pharmaceutical Manufacturing

    Biopharma

    Biotechnology

    Oncology

    Pharmaceuticals